• 1
    Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113: 832836.
  • 2
    Hertzen L, Haahtela T. Signs of reversing trends in prevalence of asthma. Allergy 2005;60: 283292.
  • 3
    Ring J, Kramer U, Darsow U, Behrendt H. Why are allergies increasing? Curr Opin Immunol 2001;13: 701708.
  • 4
    Williams CM, Galli SJ. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 2000;105: 847859.
  • 5
    Boyce JA. Mast cells: beyond IgE. J Allergy Clin Immunol 2003;111: 2432.
  • 6
    Marshall JS, Jawdat DM. Mast cells in innate immunity. J Allergy Clin Immunol 2004;114: 2127.
  • 7
    Siraganian RP. Mast cell signal transduction from the high-affinity IgE receptor. Curr Opin Immunol 2003;15: 639646.
  • 8
    Miller HR, Pemberton AD. Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 2002;105: 375390.
  • 9
    Steinke JW, Borish L, Rosenwasser LJ. Genetics of hypersensitivity. J Allergy Clin Immunol 2003;111: S495-S501.
  • 10
    Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002;4: 4561.
  • 11
    Moffatt MF, Hill MR, Cornelis F, Schou C, Faux JA, Young RP et al, Genetic linkage of T-cell receptor alpha/delta complex to specific IgE responses. Lancet 1994;343: 15971600.
  • 12
    The Collaborative Study on the Genetics of Asthma (CSGA). A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nat Genet 1997;15: 389392.
  • 13
    Mao XQ, Shirakawa T, Yoshikawa T, Yoshikawa K, Kawai M, Sasaki S et al. Association between genetic variants of mast-cell chymase and eczema. Lancet 1996;348: 581583.
  • 14
    Mao XQ, Shirakawa T, Enomoto T, Shimazu S, Dake Y, Kitano H et al. Association between variants of mast cell chymase gene and serum IgE levels in eczema. Hum Hered 1998;48: 3841.
  • 15
    Tanaka K, Sugiura H, Uehara M, Sato H, Hashimoto-Tamaoki T, Furuyama J. Association between mast cell chymase genotype and atopic eczema: comparison between patients with atopic eczema alone and those with atopic eczema and atopic respiratory disease. Clin Exp Allergy 1999;29: 800803.
  • 16
    Kawashima T, Noguchi E, Arinami T, Kobayashi K, Otsuka F, Hamaguchi H. No evidence for an association between a variant of the mast cell chymase gene and atopic dermatitis based on case-control and haplotype-relative-risk analyses. Hum Hered 1998;48: 271274.
  • 17
    Pascale E, Tarani L, Meglio P, Businco L, Battiloro E, Cimino-Reale G et al. Absence of association between a variant of the mast cell chymase gene and atopic dermatitis in an Italian population. Hum Hered 2001;51: 1771717719.
  • 18
    Iwanaga T, McEuen A, Walls AF, Clough JB, Keith TP, Rorke S et al. Polymorphism of the mast cell chymase gene (CMA1) promoter region: lack of association with asthma but association with serum total immunoglobulin E levels in adult atopic dermatitis. Clin Exp Allergy 2004;34: 10371042.
  • 19
    Weidinger S, Klopp N, Wagenpfeil S, Rümmler L, Schedel M, Kabesch M et al. Association of a STAT 6 haplotype with elevated serum IgE levels in a population-based cohort of caucasian adults. J Med Gen 2004;41: 658663.
  • 20
    Illig T, Bongardt F, Schöpfer A, Holle R, Müller S, Rathmann W et al. The endotoxin receptor TLR 4 polymorphism is not associated with diabetes or components of the metabolic syndrome. Diabetes 2003;52: 28612864.
  • 21
    Burney PG, Luczynska C, Chinn S, Jarvis D. The European Community Respiratory Health Survey. Eur Respir J 1994;7: 954960.
  • 22
    Hanifin JM, Rajka G. Diagnostic features of atoopic dermatitis. Acta Dermatovenereol 1980;92: 4447.
  • 23
    Williams H, Burney PG, Hay RJ, Archer CB, Shipley MJ, Hunter J et al. The UK working party's diagnostic criteria for atopic eczema. I. Derivation of a minimum set of discriminators for atopic eczema. Br J Dermatol 1994;131: 383396.
  • 24
    Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995;12: 921927.
  • 25
    Slatkin M, Excoffier L. Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm. Heredity 1996;76: 377383.
  • 26
    Jarvis D, Chinn S, Luczynska C, Burney P. The association of smoking with sensitivity to common allergens: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999;104: 934940.
  • 27
    SAS II. SAS/Genetics(r) User's Guide. NC, USA: Cary, 2002.
  • 28
    Deichmann KA, Hildebrandt F, Kuehr J, Forster J. Genetic linkage analysis of predicted asthma genes and atopy. Allergy 1995;50: 164.
  • 29
    Cookson W. Genetics and genomics of asthma and allergic diseases. Immunol Rev 2002;190: 195206.
  • 30
    Stephens JC, Schneider JA, Tanguay DA, Choi J, Acharya T, Stanley SE et al. Haplotype variation and linkage disequilibrium in 313 human genes. Science 2000;293: 489493.
  • 31
    Badertscher K, Bronnimann M, Karlen S, Braathen LR, Yawalkar N. Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis. Arch Dermatol Res 2005;296: 503536.
  • 32
    Groneberg DA, Bester C, Grutzkau A, Serowka F, Fischer A, Henz BM et al. Mast cells and vasculature in atopic dermatitis–potential stimulus of neoangiogenesis. Allergy 2005;60: 9097.
  • 33
    Imada T, Komorita N, Kobayashi F, Naito K, Yoshikawa T, Miyazaki M et al. Therapeutic potential of a specific chymase inhibitor in atopic dermatitis. Jpn J Pharmacol 2002;90: 214217.
  • 34
    Watanabe N, Tomimori Y, Saito K, Miura K, Wada A, Tsudzuki M et al. Chymase inhibitor improves dermatitis in NC/Nga mice. Int Arch Allergy Immunol 2002;128: 229234.